PuraPly™ is a type I collagen matrix intended for the management of acute and chronic wounds, including partial- and full-thickness wounds, pressure ulcers, surgical wounds, trauma wounds, venous and diabetic ulcers.
• A purified collagen wound matrix consisting of a single layer fenestrated sheet of inherently strong and biocompatible porcine-derived collagen
PuraPly™ Wound Matrix is indicated for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears), and draining wounds. This device is intended for single patient use only. Do not reuse.
This device is derived from a porcine source and should not be used in patients with known sensitivity to porcine materials.
The device is not indicated for use in third-degree burns.
Do not resterilize. Discard all open and unused portions of PuraPly™ Wound Matrix.
Device is sterile if the package is dry, unopened and undamaged. Do not use if the package seal is broken.
The device must be used prior to the expiration date.
Discard device if mishandling has caused possible damage or contamination.
PuraPly™ Wound Matrix should not be applied until excessive exudates, bleeding, acute swelling and infection are controlled.
The following complications are possible with the use of wound dressings. If any of these conditions occur, the device should be removed.
• Chronic inflammation (Initial application of wound dressings may be associated with transient, mild, localized inflammation.)
• Allergic reaction
• Excessive redness, pain, swelling or blistering
Do not freeze or expose to excessive heat.
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for venous ulcers||●|
|Indicated for third-degree burns|
|Contact manufacturer for usage guidelines|
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available|
|Published Clinical Article Available||●|
Granulating/ Epithelializing Wounds
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Always handle PuraPly™ Wound Matrix using aseptic technique. Prepare wound area using standard methods to ensure wound is free of debris and necrotic tissue. If necessary, surgically debride the wound to ensure the wound edges contain viable tissue. To apply, cut the dry sheet to the outline of the wound area. If the wound is larger than a single sheet, then multiple sheets may be used. Overlap adjoining sheets to provide coverage of the entire wound. For ease of handling, apply PuraPly™ Wound Matrix by placing in a dry state over the wound and rehydrate the sheet using sterile saline or other isotonic solution. Place the edge of the sheet in contact with the intact tissue. Smooth PuraPly™ Wound Matrix into place to ensure the sheet is in contact with the underlying wound bed. The sheet may be fixed to the wound using sutures or other fixation method. The optimum fixation method is determined by wound location, size, depth and user preference.
NOTE: If excess exudate collects under the sheet, small openings can be cut in the sheet to allow the exudates to drain.
After application, use an appropriate, non-adherent, secondary dressing to maintain a moist wound environment. The optimum secondary dressing is determined by wound location, size, depth and user preference. Change the secondary dressing as needed to maintain a moist, clean wound area. Frequency of secondary dressing change will be dependent upon volume of exudate produced and type of dressing used. As healing occurs, sections of PuraPly™ Wound Matrix may gradually peel and may be removed during dressing changes. Do not forcibly remove sections of PuraPly™ Wound Matrix that may adhere to the wound. Alternatively, the PuraPly™ Wound Matrix may form into a caramel-colored gel, which can be rinsed away with gentle irrigation. On inspection, if PuraPly™ Wound Matrix is no longer covering the wound, place an additional piece of PuraPly™ Wound Matrix over the wound. The wound should be reevaluated on a weekly basis for PuraPly™ reapplication.
Originally founded as a spin-off from technology developed at MIT in 1985, Massachusetts-based Organogenesis Inc. is a global leader in regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products for advanced wound care, orthopedics, and spine. Organogenesis' versatile portfolio is designed to treat a variety of patients with repair and regenerative needs.